NasdaqGS - Nasdaq Real Time Price USD

Vaxcyte, Inc. (PCVX)

65.69 +0.12 (+0.18%)
As of 1:08 PM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
432,084.00
388,276.00
207,330.00
102,085.00
87,103.00
Operating Income
-432,084.00
-388,276.00
-207,330.00
-102,085.00
-87,103.00
Net Non Operating Interest Income Expense
74,180.00
62,907.00
8,354.00
337.00
237.00
Other Income Expense
-78,920.00
-76,897.00
-24,509.00
1,671.00
-2,351.00
Pretax Income
-436,824.00
-402,266.00
-223,485.00
-100,077.00
-89,217.00
Net Income Common Stockholders
-436,824.00
-402,266.00
-223,485.00
-100,077.00
-89,217.00
Diluted NI Available to Com Stockholders
-436,824.00
-402,266.00
-223,485.00
-100,077.00
-89,217.00
Basic EPS
-4.29
-4.14
-3.44
-1.93
-3.02
Diluted EPS
-4.29
-4.14
-3.44
-1.93
-3.02
Basic Average Shares
103,528.72
97,157.69
64,877.99
51,922.11
29,545.81
Diluted Average Shares
103,528.72
97,157.69
64,877.99
51,922.11
29,545.81
Total Operating Income as Reported
-511,321.00
-468,041.00
-232,256.00
-103,670.00
-89,581.00
Total Expenses
432,084.00
388,276.00
207,330.00
102,085.00
87,103.00
Net Income from Continuing & Discontinued Operation
-436,824.00
-402,266.00
-223,485.00
-100,077.00
-89,217.00
Normalized Income
-357,904.00
-325,369.00
-198,976.00
-101,748.00
-86,866.00
Interest Income
74,180.00
62,907.00
8,356.00
344.00
244.00
Interest Expense
--
--
2.00
7.00
7.00
Net Interest Income
74,180.00
62,907.00
8,354.00
337.00
237.00
EBIT
-446,074.00
-402,266.00
-223,483.00
-100,070.00
-89,210.00
EBITDA
-435,154.00
-392,095.00
-214,287.00
-96,613.00
-87,805.00
Reconciled Depreciation
10,920.00
10,171.00
9,196.00
3,457.00
1,405.00
Net Income from Continuing Operation Net Minority Interest
-436,824.00
-402,266.00
-223,485.00
-100,077.00
-89,217.00
Total Unusual Items Excluding Goodwill
-78,920.00
-76,897.00
-24,509.00
1,671.00
-2,351.00
Total Unusual Items
-78,920.00
-76,897.00
-24,509.00
1,671.00
-2,351.00
Normalized EBITDA
-356,234.00
-315,198.00
-189,778.00
-98,284.00
-85,454.00
12/31/2020 - 6/12/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

LEGN Legend Biotech Corporation
44.07
-3.19%
 
ASND Ascendis Pharma A/S
133.62
+0.36%
 
RVMD Revolution Medicines, Inc.
37.62
+0.44%
 
IDYA IDEAYA Biosciences, Inc.
40.72
+0.18%
 
NRIX Nurix Therapeutics, Inc.
13.37
-4.16%
 
KYMR Kymera Therapeutics, Inc.
38.02
-1.53%
 
ITOS iTeos Therapeutics, Inc.
17.90
+46.84%
 
NUVL Nuvalent, Inc.
64.79
-4.04%
 
MRUS Merus N.V.
44.73
-0.86%
 
IMVT Immunovant, Inc.
29.91
+0.71%